187 related articles for article (PubMed ID: 16584427)
1. Implementation of peripheral blood CD34 analyses to initiate leukapheresis: marked reduction in resource utilization.
Meehan KR; Hill JM; Patchett L; Webber SM; Wu J; Ely P; Szczepiorkowski ZM
Transfusion; 2006 Apr; 46(4):523-9. PubMed ID: 16584427
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis.
Lefrère F; Zohar S; Beaudier S; Audat F; Ribeil JA; Ghez D; Varet B; Cavazzana-Calvo M; Dal Cortivo L; Letestu R; McIntyre E; Brouzes C
Transfusion; 2007 Oct; 47(10):1851-7. PubMed ID: 17880611
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells.
de Fabritiis P; Gonzalez M; Meloni G; De Propris MS; Bellucci R; Cordone I; Gozzer M; Leone G; Mandelli F
Bone Marrow Transplant; 1999 Jun; 23(12):1229-36. PubMed ID: 10414908
[TBL] [Abstract][Full Text] [Related]
4. Correlation of hematopoietic progenitor cell count determined by the SE-automated hematology analyzer with CD34(+) cell count by flow cytometry in leukapheresis products.
Park KU; Kim SH; Suh C; Kim S; Lee SJ; Park JS; Cho HJ; Kim KW; Lee K; Kim HJ; Park J; Joo Min Y; Kim JG; Kim T; Lee JH; Kim SB; Kim SW; Lee KH; Lee JS; Kim WK; Park CJ; Chi HS
Am J Hematol; 2001 May; 67(1):42-7. PubMed ID: 11279656
[TBL] [Abstract][Full Text] [Related]
5. The number of CD34(+) cells in peripheral blood as a predictor of the CD34(+) yield in patients going to autologous stem cell transplantation.
Basquiera AL; Abichain P; Damonte JC; Ricchi B; Sturich AG; Palazzo ED; García JJ
J Clin Apher; 2006 Jul; 21(2):92-5. PubMed ID: 16106446
[TBL] [Abstract][Full Text] [Related]
6. Improving the efficiency of PBPC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cells.
Lane TA; Bashey A; Carrier E; Holman P; Castro J; Mullen M; Ward DM; Ada O; Ball ED
Cytotherapy; 2004; 6(4):318-27. PubMed ID: 16146884
[TBL] [Abstract][Full Text] [Related]
7. PBPC collection techniques: standard versus large volume leukapheresis (LVL) in donors and in patients.
Gasová Z; Marinov I; Vodvárková S; Böhmová M; Bhuyian-Ludvíková Z
Transfus Apher Sci; 2005 Apr; 32(2):167-76. PubMed ID: 15784451
[TBL] [Abstract][Full Text] [Related]
8. Correlation of CD34+ cell yield in peripheral blood progenitor cell product with the pre-leukapheresis cell counts in peripheral blood.
Sawant RB; Rajadhyaksha SB
J Assoc Physicians India; 2005 Dec; 53():1031-5. PubMed ID: 16572958
[TBL] [Abstract][Full Text] [Related]
9. Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization.
Fu P; Bagai RK; Meyerson H; Kane D; Fox RM; Creger RJ; Cooper BW; Gerson SL; Laughlin MJ; Koc ON; Lazarus HM
Bone Marrow Transplant; 2006 Aug; 38(3):189-96. PubMed ID: 16850032
[TBL] [Abstract][Full Text] [Related]
10. Progenitor cell recruitment during individualized high-flow, very-large-volume apheresis for autologous transplantation improves collection efficiency.
Fontana S; Groebli R; Leibundgut K; Pabst T; Zwicky C; Taleghani BM
Transfusion; 2006 Aug; 46(8):1408-16. PubMed ID: 16934079
[TBL] [Abstract][Full Text] [Related]
11. Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells.
Abrahamsen JF; Stamnesfet S; Liseth K; Hervig T; Bruserud O
Transfusion; 2005 Feb; 45(2):248-53. PubMed ID: 15660835
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of a new automated system employed for peripheral blood stem cell collection.
Del Fante C; Perotti C; Viarengo G; Bellotti L; Parisi C; Marchesi A; Tinelli C; Salvaneschi L
J Clin Apher; 2006 Dec; 21(4):227-32. PubMed ID: 16847939
[TBL] [Abstract][Full Text] [Related]
13. Comparison of processing four and five times the patients' blood volume during peripheral blood stem cell collection and analysis of CD34+38--and CD34+49d+ subsets during apheresis.
Bojko P; Scharifi M; Stössel K; Seeber S
J Cancer Res Clin Oncol; 2002 Jan; 128(1):19-28. PubMed ID: 11862468
[TBL] [Abstract][Full Text] [Related]
14. EPO in combination with G-CSF improves mobilization effectiveness after chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs during mobilization and transplantation of autologous hematopoietic progenitor cells.
Hart C; Grassinger J; Andreesen R; Hennemann B
Bone Marrow Transplant; 2009 Feb; 43(3):197-206. PubMed ID: 18806833
[TBL] [Abstract][Full Text] [Related]
15. In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.
Villaron EM; Almeida J; Lopez-Holgado N; Sanchez-Guijo FM; Alberca M; Blanco B; Sanchez-Abarca LI; Lopez O; Perez-Simon JA; San Miguel JF; del Cañizo MC
Transfus Apher Sci; 2007 Oct; 37(2):145-56. PubMed ID: 17983836
[TBL] [Abstract][Full Text] [Related]
16. Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?
Gidron A; Verma A; Doyle M; Boggio L; Evens A; Gordon L; Singhal S; Tallman M; Williams S; Winter J; Mehta J
Bone Marrow Transplant; 2005 Feb; 35(3):243-6. PubMed ID: 15580281
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
Callera F; Cavenaghi L; de Melo CM
Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
[TBL] [Abstract][Full Text] [Related]
18. Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation.
Statkute L; Verda L; Oyama Y; Traynor A; Villa M; Shook T; Clifton R; Jovanovic B; Satkus J; Loh Y; Quigley K; Yaung K; Gonda E; Krosnjar N; Spahovic D; Burt RK
Bone Marrow Transplant; 2007 Mar; 39(6):317-29. PubMed ID: 17277794
[TBL] [Abstract][Full Text] [Related]
19. Large volume leukapheresis in small children: safety profile and variables affecting peripheral blood progenitor cell collection.
Sevilla J; González-Vicent M; Madero L; García-Sánchez F; Angel Diaz M
Bone Marrow Transplant; 2003 Feb; 31(4):263-7. PubMed ID: 12621460
[TBL] [Abstract][Full Text] [Related]
20. Prediction of target CD34 positive cells following leukopheresis in children with neuroblastoma.
Schroeder H; Kamperis K; Grunnet N; Hokland P
Pediatr Blood Cancer; 2006 Jun; 46(7):786-92. PubMed ID: 16333829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
